StockClub
GLPGFLakefront Biotherapeutics$ --
Lakefront Biotherapeutics

Lakefront Biotherapeutics

GLPGF

$ -

-

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

analyticsIncome Statement Summary

FY2025 Full YearUpdated: 12/31/2025

Revenue

attach_money
1,112M EUR
YoY +303.4%

Operating Income

bar_chart
469M EUR
YoY +349.3%

Net Income

verified
321M EUR
YoY +333.0%

EPS

pie_chart
4.87EUR
YoY +334.8%

Quarterly Performance

Quarterly revenue and net income trend

RevenueOperating IncomeNet Income
No quarterly data available

Full-Year Progress

FY2025
Net Income Progress-100.7%Below Target
Revenue Progress1.1B
Revenue Forecast268.6M
Net Income Progress320.6M
Net Income Forecast-318.4M

Income Statement Details

Item
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Revenue
Cost of revenue
Gross profit
1,112
30
1,082
Research & development
Selling & marketing
Selling, general and administrative
Other operating expenses
Operating income
459
0
153
642
469
Interest expense
Income before tax
Income tax expense
Net income
3
301
-19
321

Unlock Long-Term Income Statement Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.